Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

  • Home
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Patents
    • FAQ
  • Solutions
    • For Pharma & Biotech
    • For Manufacturers
    • For Investors
  • Pipeline
  • About
    • Mission
    • The Problem We Solve
    • Licensing Model
    • Leadership
  • News
  • Contact
  • More
    • Home
    • Technology
      • Our Science
      • Demonstration
      • Stability Studies
      • ATR-FTIR
      • Patents
      • FAQ
    • Solutions
      • For Pharma & Biotech
      • For Manufacturers
      • For Investors
    • Pipeline
    • About
      • Mission
      • The Problem We Solve
      • Licensing Model
      • Leadership
    • News
    • Contact

Mingowood Pharmacal

Mingowood PharmacalMingowood PharmacalMingowood Pharmacal

Signed in as:

filler@godaddy.com

  • Home
  • Technology
    • Our Science
    • Demonstration
    • Stability Studies
    • ATR-FTIR
    • Patents
    • FAQ
  • Solutions
    • For Pharma & Biotech
    • For Manufacturers
    • For Investors
  • Pipeline
  • About
    • Mission
    • The Problem We Solve
    • Licensing Model
    • Leadership
  • News
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Cannabis and Wellness Manufacturers

Stop Losing Potency. Start Delivering on Your Label Claims.

CBDA, THCA, CBGA, and CBCA degrade quickly after purification. Light, heat, and oxygen convert them into less potent compounds, and in the case of THCA, psychoactive ones, before your product reaches a consumer. When that happens, your label claims no longer reflect what is in the bottle, and your shelf life is compromised.

  

Mingowood Pharmacal’s Intercalyx™ platform fixes this. Our patented formulation intercalates acidic cannabinoids into layered double hydroxides, forming a stable matrix that inhibits decarboxylation and oxidation. The outcome is consistent potency, accurate dosing, a shelf life of more than 2 years, and no cold-chain requirement.


What this means for your products

  • Label claims you can stand behind, with batch-to-batch consistency guaranteed.
  • Shelf life extended beyond two years without refrigeration.
  • Taste and smell masking, which means a better consumer experience.
  • Compatible with capsule, powder, dispersible, sublingual, and liquid formats.
  • THCA formulations that remain non-psychoactive in the bottle.


Learn more about @LDH

Request Technical DataTalk to Our Team

Mingowood Pharmacal

Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept